These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17045077)

  • 1. Alterations in lipoprotein defense against oxidative stress in metabolic syndrome.
    Hansel B; Kontush A; Bonnefont-Rousselot D; Bruckert E; Chapman MJ
    Curr Atheroscler Rep; 2006 Nov; 8(6):501-9. PubMed ID: 17045077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels.
    Hansel B; Bonnefont-Rousselot D; Orsoni A; Bittar R; Giral P; Roussel R; Marre M; Mohammedi K; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(5):1172-81. PubMed ID: 27678434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
    Kontush A; Chapman MJ
    Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.
    Hansel B; Giral P; Nobecourt E; Chantepie S; Bruckert E; Chapman MJ; Kontush A
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4963-71. PubMed ID: 15472192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity.
    Park KH; Shin DG; Kim JR; Hong JH; Cho KH
    Int J Mol Med; 2010 Jan; 25(1):129-36. PubMed ID: 19956911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
    Tiniakou I; Kanaki Z; Georgopoulos S; Chroni A; Van Eck M; Fotakis P; Zannis VI; Kardassis D
    Atherosclerosis; 2015 Nov; 243(1):77-85. PubMed ID: 26363436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality.
    Cho KH
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences Between Morbid Obesity With Metabolic Syndrome and Overweight Turkish Adult Participants in Multiple Atherosclerotic Cardiovascular Disease Risk Factors.
    Bostan C; Kaya A; Yigit Z
    Angiology; 2021 Feb; 72(2):131-137. PubMed ID: 33143460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
    Moradi H; Pahl MV; Elahimehr R; Vaziri ND
    Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
    Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
    Groener JE; van Gent T; van Tol A
    Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
    Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
    Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication of CETP.
    Chapman MJ; Orsoni A; Robillard P; Therond P; Giral P
    J Clin Lipidol; 2018; 12(3):784-800.e4. PubMed ID: 29574070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.
    Kontush A; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1881-8. PubMed ID: 12920049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
    Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.
    Quaschning T; Krane V; Metzger T; Wanner C
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.
    Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.